JPRN-UMIN000017751已完成未知
Phase I/II study of gemcitabine and nab-paclitaxel with radiation therapy in patients with pancreatic cancer. - Phase I/II study of GEM + nab-PTX + radiation therapy in patients with pancreatic cancer.
Department of Surgery, Keio University School of Medicine0 个研究点目标入组 30 人开始时间: 2015年5月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)bowel movement control is difficult, because of watery diarrhea and chronic diarrhea. (2)Interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray and with symptom (3)Pleural effusion or ascitic fluid accumulates (4)with clinically important infection (5)has active carcinoma except carcinoma in situ (6)with gastrointestinal active ulcer (7)sever complication(heart failure, renal failure,liver failure,intestinal paralysis,uncontrollable diabetes etc) (8)severe mental disorder (9)severe drug allergy (10)pregnant women or during the nursing, women who like be pregnant and willing to get pregnant (11)doctors decision not to be registered to this study
研究者
相似试验
已完成
不适用
A phase II study of gemcitabine and nab-paclitaxel followed by chemoradiotherapy with S-1 in patients with locally advanced pancreatic cancerJPRN-UMIN000026525Chiba Cancer Center30
已完成
不适用
Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinomapancreatic cancerJPRN-UMIN000030551Mie university15
进行中（未招募）
1 期
Study of Nab-paclitaxel and Gemcitabine in Elderly Patients with Pancreatic CancerMetastatic pancreatic cancerMedDRA version: 17.1 Level: PT Classification code 10033610 Term: Pancreatic carcinoma metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-003596-27-ESAsociación de Oncología Médica del Hospital de Cruces (ASONMEC)80
已完成
2 期
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
已完成
2 期
Phase II study of gemcitabine plus nab-Pacletaxel as second-line therapy after FOLFIRINOX for advanced pancreatic canceradvanced pancreatic cancerJPRN-UMIN000016624Gifu University Hospital30